Global Kidney Cancer Diagnostics Market Research Report 2023

Kidney Cancer Diagnostics Market

Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes. 

The global Kidney Cancer Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Kidney Cancer Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Kidney Cancer Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Kidney Cancer Diagnostics include Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies and Sysmex Corporation, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Diagnostics.

The Kidney Cancer Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Kidney Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Kidney Cancer Diagnostics Market Report

Core Chapters

1.1 Product Overview and Scope of Kidney Cancer Diagnostics

1.2 Kidney Cancer Diagnostics Segment by Type

1.2.1 Global Kidney Cancer Diagnostics Market Value Comparison by Type (2023-2029)

1.2.2 Immunohistochemistry

1.2.3 Urine Analysis

1.2.4 Blood Chemistry Test

1.2.5 Others

1.3 Kidney Cancer Diagnostics Segment by Application

1.3.1 Global Kidney Cancer Diagnostics Market Value by Application: (2023-2029)

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Others

1.4 Global Kidney Cancer Diagnostics Market Size Estimates and Forecasts

1.4.1 Global Kidney Cancer Diagnostics Revenue 2018-2029

1.4.2 Global Kidney Cancer Diagnostics Sales 2018-2029

1.4.3 Global Kidney Cancer Diagnostics Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Kidney Cancer Diagnostics Sales Market Share by Manufacturers (2018-2023)

2.2 Global Kidney Cancer Diagnostics Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Kidney Cancer Diagnostics Average Price by Manufacturers (2018-2023)

2.4 Global Kidney Cancer Diagnostics Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Kidney Cancer Diagnostics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Kidney Cancer Diagnostics, Product Type & Application

2.7 Kidney Cancer Diagnostics Market Competitive Situation and Trends

2.7.1 Kidney Cancer Diagnostics Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Kidney Cancer Diagnostics Players Market Share by Revenue

2.7.3 Global Kidney Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Kidney Cancer Diagnostics Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Kidney Cancer Diagnostics Global Kidney Cancer Diagnostics Sales by Region: 2018-2029

3.2.1 Global Kidney Cancer Diagnostics Sales by Region: 2018-2023

3.2.2 Global Kidney Cancer Diagnostics Sales by Region: 2024-2029

3.3 Global Kidney Cancer Diagnostics Global Kidney Cancer Diagnostics Revenue by Region: 2018-2029

3.3.1 Global Kidney Cancer Diagnostics Revenue by Region: 2018-2023

3.3.2 Global Kidney Cancer Diagnostics Revenue by Region: 2024-2029

3.4 North America Kidney Cancer Diagnostics Market Facts & Figures by Country

3.4.1 North America Kidney Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Kidney Cancer Diagnostics Sales by Country (2018-2029)

3.4.3 North America Kidney Cancer Diagnostics Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Kidney Cancer Diagnostics Market Facts & Figures by Country

3.5.1 Europe Kidney Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Kidney Cancer Diagnostics Sales by Country (2018-2029)

3.5.3 Europe Kidney Cancer Diagnostics Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Kidney Cancer Diagnostics Market Facts & Figures by Country

3.6.1 Asia Pacific Kidney Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Kidney Cancer Diagnostics Sales by Country (2018-2029)

3.6.3 Asia Pacific Kidney Cancer Diagnostics Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Kidney Cancer Diagnostics Market Facts & Figures by Country

3.7.1 Latin America Kidney Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Kidney Cancer Diagnostics Sales by Country (2018-2029)

3.7.3 Latin America Kidney Cancer Diagnostics Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Kidney Cancer Diagnostics Market Facts & Figures by Country

3.8.1 Middle East and Africa Kidney Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Kidney Cancer Diagnostics Sales by Country (2018-2029)

3.8.3 Middle East and Africa Kidney Cancer Diagnostics Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Kidney Cancer Diagnostics Sales by Type (2018-2029)

4.1.1 Global Kidney Cancer Diagnostics Sales by Type (2018-2023)

4.1.2 Global Kidney Cancer Diagnostics Sales by Type (2024-2029)

4.1.3 Global Kidney Cancer Diagnostics Sales Market Share by Type (2018-2029)

4.2 Global Kidney Cancer Diagnostics Revenue by Type (2018-2029)

4.2.1 Global Kidney Cancer Diagnostics Revenue by Type (2018-2023)

4.2.2 Global Kidney Cancer Diagnostics Revenue by Type (2024-2029)

4.2.3 Global Kidney Cancer Diagnostics Revenue Market Share by Type (2018-2029)

4.3 Global Kidney Cancer Diagnostics Price by Type (2018-2029)

5.1 Global Kidney Cancer Diagnostics Sales by Application (2018-2029)

5.1.1 Global Kidney Cancer Diagnostics Sales by Application (2018-2023)

5.1.2 Global Kidney Cancer Diagnostics Sales by Application (2024-2029)

5.1.3 Global Kidney Cancer Diagnostics Sales Market Share by Application (2018-2029)

5.2 Global Kidney Cancer Diagnostics Revenue by Application (2018-2029)

5.2.1 Global Kidney Cancer Diagnostics Revenue by Application (2018-2023)

5.2.2 Global Kidney Cancer Diagnostics Revenue by Application (2024-2029)

5.2.3 Global Kidney Cancer Diagnostics Revenue Market Share by Application (2018-2029)

5.3 Global Kidney Cancer Diagnostics Price by Application (2018-2029)

6.1 Thermo Fisher Scientific

6.1.1 Thermo Fisher Scientific Corporation Information

6.1.2 Thermo Fisher Scientific Description and Business Overview

6.1.3 Thermo Fisher Scientific Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Thermo Fisher Scientific Kidney Cancer Diagnostics Product Portfolio

6.1.5 Thermo Fisher Scientific Recent Developments/Updates

6.2 Abbott Laboratories

6.2.1 Abbott Laboratories Corporation Information

6.2.2 Abbott Laboratories Description and Business Overview

6.2.3 Abbott Laboratories Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Abbott Laboratories Kidney Cancer Diagnostics Product Portfolio

6.2.5 Abbott Laboratories Recent Developments/Updates

6.3 Illumina

6.3.1 Illumina Corporation Information

6.3.2 Illumina Description and Business Overview

6.3.3 Illumina Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Illumina Kidney Cancer Diagnostics Product Portfolio

6.3.5 Illumina Recent Developments/Updates

6.4 Quest Diagnostics Incorporated

6.4.1 Quest Diagnostics Incorporated Corporation Information

6.4.2 Quest Diagnostics Incorporated Description and Business Overview

6.4.3 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product Portfolio

6.4.5 Quest Diagnostics Incorporated Recent Developments/Updates

6.5 Roche Holding

6.5.1 Roche Holding Corporation Information

6.5.2 Roche Holding Description and Business Overview

6.5.3 Roche Holding Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Roche Holding Kidney Cancer Diagnostics Product Portfolio

6.5.5 Roche Holding Recent Developments/Updates

6.6 Myriad Genetics

6.6.1 Myriad Genetics Corporation Information

6.6.2 Myriad Genetics Description and Business Overview

6.6.3 Myriad Genetics Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Myriad Genetics Kidney Cancer Diagnostics Product Portfolio

6.6.5 Myriad Genetics Recent Developments/Updates

6.7 NeoGenomics Laboratories

6.6.1 NeoGenomics Laboratories Corporation Information

6.6.2 NeoGenomics Laboratories Description and Business Overview

6.6.3 NeoGenomics Laboratories Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.4.4 NeoGenomics Laboratories Kidney Cancer Diagnostics Product Portfolio

6.7.5 NeoGenomics Laboratories Recent Developments/Updates

6.8 NanoString Technologies

6.8.1 NanoString Technologies Corporation Information

6.8.2 NanoString Technologies Description and Business Overview

6.8.3 NanoString Technologies Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.8.4 NanoString Technologies Kidney Cancer Diagnostics Product Portfolio

6.8.5 NanoString Technologies Recent Developments/Updates

6.9 Sysmex Corporation

6.9.1 Sysmex Corporation Corporation Information

6.9.2 Sysmex Corporation Description and Business Overview

6.9.3 Sysmex Corporation Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Sysmex Corporation Kidney Cancer Diagnostics Product Portfolio

6.9.5 Sysmex Corporation Recent Developments/Updates

6.10 Rosetta Genomics

6.10.1 Rosetta Genomics Corporation Information

6.10.2 Rosetta Genomics Description and Business Overview

6.10.3 Rosetta Genomics Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Rosetta Genomics Kidney Cancer Diagnostics Product Portfolio

6.10.5 Rosetta Genomics Recent Developments/Updates

7.1 Kidney Cancer Diagnostics Industry Chain Analysis

7.2 Kidney Cancer Diagnostics Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Kidney Cancer Diagnostics Production Mode & Process

7.4 Kidney Cancer Diagnostics Sales and Marketing

7.4.1 Kidney Cancer Diagnostics Sales Channels

7.4.2 Kidney Cancer Diagnostics Distributors

7.5 Kidney Cancer Diagnostics Customers

8.1 Kidney Cancer Diagnostics Industry Trends

8.2 Kidney Cancer Diagnostics Market Drivers

8.3 Kidney Cancer Diagnostics Market Challenges

8.4 Kidney Cancer Diagnostics Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Kidney Cancer Diagnostics Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Kidney Cancer Diagnostics Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Kidney Cancer Diagnostics Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Kidney Cancer Diagnostics Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Kidney Cancer Diagnostics Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Kidney Cancer Diagnostics Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Kidney Cancer Diagnostics Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Kidney Cancer Diagnostics, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Kidney Cancer Diagnostics, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Kidney Cancer Diagnostics, Product Type & Application

    Table 12. Global Key Manufacturers of Kidney Cancer Diagnostics, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Kidney Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnostics as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Kidney Cancer Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Kidney Cancer Diagnostics Sales by Region (2018-2023) & (K Units)

    Table 18. Global Kidney Cancer Diagnostics Sales Market Share by Region (2018-2023)

    Table 19. Global Kidney Cancer Diagnostics Sales by Region (2024-2029) & (K Units)

    Table 20. Global Kidney Cancer Diagnostics Sales Market Share by Region (2024-2029)

    Table 21. Global Kidney Cancer Diagnostics Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Kidney Cancer Diagnostics Revenue Market Share by Region (2018-2023)

    Table 23. Global Kidney Cancer Diagnostics Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Kidney Cancer Diagnostics Revenue Market Share by Region (2024-2029)

    Table 25. North America Kidney Cancer Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Kidney Cancer Diagnostics Sales by Country (2018-2023) & (K Units)

    Table 27. North America Kidney Cancer Diagnostics Sales by Country (2024-2029) & (K Units)

    Table 28. North America Kidney Cancer Diagnostics Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Kidney Cancer Diagnostics Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Kidney Cancer Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Kidney Cancer Diagnostics Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Kidney Cancer Diagnostics Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Kidney Cancer Diagnostics Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Kidney Cancer Diagnostics Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Kidney Cancer Diagnostics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Kidney Cancer Diagnostics Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Kidney Cancer Diagnostics Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Kidney Cancer Diagnostics Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Kidney Cancer Diagnostics Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Kidney Cancer Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Kidney Cancer Diagnostics Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Kidney Cancer Diagnostics Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Kidney Cancer Diagnostics Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Kidney Cancer Diagnostics Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Kidney Cancer Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Kidney Cancer Diagnostics Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Kidney Cancer Diagnostics Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Kidney Cancer Diagnostics Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Kidney Cancer Diagnostics Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Kidney Cancer Diagnostics Sales (K Units) by Type (2018-2023)

    Table 51. Global Kidney Cancer Diagnostics Sales (K Units) by Type (2024-2029)

    Table 52. Global Kidney Cancer Diagnostics Sales Market Share by Type (2018-2023)

    Table 53. Global Kidney Cancer Diagnostics Sales Market Share by Type (2024-2029)

    Table 54. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Kidney Cancer Diagnostics Revenue Market Share by Type (2018-2023)

    Table 57. Global Kidney Cancer Diagnostics Revenue Market Share by Type (2024-2029)

    Table 58. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Kidney Cancer Diagnostics Sales (K Units) by Application (2018-2023)

    Table 61. Global Kidney Cancer Diagnostics Sales (K Units) by Application (2024-2029)

    Table 62. Global Kidney Cancer Diagnostics Sales Market Share by Application (2018-2023)

    Table 63. Global Kidney Cancer Diagnostics Sales Market Share by Application (2024-2029)

    Table 64. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Kidney Cancer Diagnostics Revenue Market Share by Application (2018-2023)

    Table 67. Global Kidney Cancer Diagnostics Revenue Market Share by Application (2024-2029)

    Table 68. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2024-2029)

    Table 70. Thermo Fisher Scientific Corporation Information

    Table 71. Thermo Fisher Scientific Description and Business Overview

    Table 72. Thermo Fisher Scientific Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Thermo Fisher Scientific Kidney Cancer Diagnostics Product

    Table 74. Thermo Fisher Scientific Recent Developments/Updates

    Table 75. Abbott Laboratories Corporation Information

    Table 76. Abbott Laboratories Description and Business Overview

    Table 77. Abbott Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Abbott Laboratories Kidney Cancer Diagnostics Product

    Table 79. Abbott Laboratories Recent Developments/Updates

    Table 80. Illumina Corporation Information

    Table 81. Illumina Description and Business Overview

    Table 82. Illumina Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Illumina Kidney Cancer Diagnostics Product

    Table 84. Illumina Recent Developments/Updates

    Table 85. Quest Diagnostics Incorporated Corporation Information

    Table 86. Quest Diagnostics Incorporated Description and Business Overview

    Table 87. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product

    Table 89. Quest Diagnostics Incorporated Recent Developments/Updates

    Table 90. Roche Holding Corporation Information

    Table 91. Roche Holding Description and Business Overview

    Table 92. Roche Holding Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Roche Holding Kidney Cancer Diagnostics Product

    Table 94. Roche Holding Recent Developments/Updates

    Table 95. Myriad Genetics Corporation Information

    Table 96. Myriad Genetics Description and Business Overview

    Table 97. Myriad Genetics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Myriad Genetics Kidney Cancer Diagnostics Product

    Table 99. Myriad Genetics Recent Developments/Updates

    Table 100. NeoGenomics Laboratories Corporation Information

    Table 101. NeoGenomics Laboratories Description and Business Overview

    Table 102. NeoGenomics Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. NeoGenomics Laboratories Kidney Cancer Diagnostics Product

    Table 104. NeoGenomics Laboratories Recent Developments/Updates

    Table 105. NanoString Technologies Corporation Information

    Table 106. NanoString Technologies Description and Business Overview

    Table 107. NanoString Technologies Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. NanoString Technologies Kidney Cancer Diagnostics Product

    Table 109. NanoString Technologies Recent Developments/Updates

    Table 110. Sysmex Corporation Corporation Information

    Table 111. Sysmex Corporation Description and Business Overview

    Table 112. Sysmex Corporation Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Sysmex Corporation Kidney Cancer Diagnostics Product

    Table 114. Sysmex Corporation Recent Developments/Updates

    Table 115. Rosetta Genomics Corporation Information

    Table 116. Rosetta Genomics Description and Business Overview

    Table 117. Rosetta Genomics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Rosetta Genomics Kidney Cancer Diagnostics Product

    Table 119. Rosetta Genomics Recent Developments/Updates

    Table 120. Key Raw Materials Lists

    Table 121. Raw Materials Key Suppliers Lists

    Table 122. Kidney Cancer Diagnostics Distributors List

    Table 123. Kidney Cancer Diagnostics Customers List

    Table 124. Kidney Cancer Diagnostics Market Trends

    Table 125. Kidney Cancer Diagnostics Market Drivers

    Table 126. Kidney Cancer Diagnostics Market Challenges

    Table 127. Kidney Cancer Diagnostics Market Restraints

    Table 128. Research Programs/Design for This Report

    Table 129. Key Data Information from Secondary Sources

    Table 130. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Kidney Cancer Diagnostics

    Figure 2. Global Kidney Cancer Diagnostics Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Kidney Cancer Diagnostics Market Share by Type in 2022 & 2029

    Figure 4. Immunohistochemistry Product Picture

    Figure 5. Urine Analysis Product Picture

    Figure 6. Blood Chemistry Test Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Kidney Cancer Diagnostics Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Kidney Cancer Diagnostics Market Share by Application in 2022 & 2029

    Figure 10. Hospitals

    Figure 11. Specialty Clinics

    Figure 12. Others

    Figure 13. Global Kidney Cancer Diagnostics Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Kidney Cancer Diagnostics Market Size (2018-2029) & (US$ Million)

    Figure 15. Global Kidney Cancer Diagnostics Sales (2018-2029) & (K Units)

    Figure 16. Global Kidney Cancer Diagnostics Average Price (US$/Unit) & (2018-2029)

    Figure 17. Kidney Cancer Diagnostics Report Years Considered

    Figure 18. Kidney Cancer Diagnostics Sales Share by Manufacturers in 2022

    Figure 19. Global Kidney Cancer Diagnostics Revenue Share by Manufacturers in 2022

    Figure 20. The Global 5 and 10 Largest Kidney Cancer Diagnostics Players: Market Share by Revenue in 2022

    Figure 21. Kidney Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 22. Global Kidney Cancer Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 23. North America Kidney Cancer Diagnostics Sales Market Share by Country (2018-2029)

    Figure 24. North America Kidney Cancer Diagnostics Revenue Market Share by Country (2018-2029)

    Figure 25. United States Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Canada Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Europe Kidney Cancer Diagnostics Sales Market Share by Country (2018-2029)

    Figure 28. Europe Kidney Cancer Diagnostics Revenue Market Share by Country (2018-2029)

    Figure 29. Germany Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. France Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. U.K. Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Italy Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Russia Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Asia Pacific Kidney Cancer Diagnostics Sales Market Share by Region (2018-2029)

    Figure 35. Asia Pacific Kidney Cancer Diagnostics Revenue Market Share by Region (2018-2029)

    Figure 36. China Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Japan Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. South Korea Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. India Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Australia Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. China Taiwan Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Indonesia Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Thailand Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Malaysia Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Kidney Cancer Diagnostics Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Kidney Cancer Diagnostics Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Kidney Cancer Diagnostics Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Kidney Cancer Diagnostics Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Kidney Cancer Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Kidney Cancer Diagnostics by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Kidney Cancer Diagnostics by Type (2018-2029)

    Figure 57. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Kidney Cancer Diagnostics by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Kidney Cancer Diagnostics by Application (2018-2029)

    Figure 60. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2018-2029)

    Figure 61. Kidney Cancer Diagnostics Value Chain

    Figure 62. Kidney Cancer Diagnostics Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed